These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8962174)

  • 21. Competition of peptide-MHC class I tetrameric complexes with anti-CD3 provides evidence for specificity of peptide binding to the TCR complex.
    Hoffmann TK; Donnenberg VS; Friebe-Hoffmann U; Meyer EM; Rinaldo CR; DeLeo AB; Whiteside TL; Donnenberg AD
    Cytometry; 2000 Dec; 41(4):321-8. PubMed ID: 11084618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The TAG family of cancer/testis antigens is widely expressed in a variety of malignancies and gives rise to HLA-A2-restricted epitopes.
    Adair SJ; Carr TM; Fink MJ; Slingluff CL; Hogan KT
    J Immunother; 2008 Jan; 31(1):7-17. PubMed ID: 18157007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Class I peptides involved in the indirect pathway of allorecognition.
    Takemoto SK
    Clin Transpl; 1997; ():317-35. PubMed ID: 9919415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human leukocyte antigen-derived peptides as novel immunosuppressives.
    Krensky AM; Clayberger C
    Proc Assoc Am Physicians; 1995 Apr; 107(1):81-5. PubMed ID: 8630749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation.
    Contini P; Ghio M; Poggi A; Filaci G; Indiveri F; Ferrone S; Puppo F
    Eur J Immunol; 2003 Jan; 33(1):125-34. PubMed ID: 12594841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human CTL epitopes prostatic acid phosphatase-3 and six-transmembrane epithelial antigen of prostate-3 as candidates for prostate cancer immunotherapy.
    Machlenkin A; Paz A; Bar Haim E; Goldberger O; Finkel E; Tirosh B; Volovitz I; Vadai E; Lugassy G; Cytron S; Lemonnier F; Tzehoval E; Eisenbach L
    Cancer Res; 2005 Jul; 65(14):6435-42. PubMed ID: 16024648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure, function, and diversity of class I major histocompatibility complex molecules.
    Bjorkman PJ; Parham P
    Annu Rev Biochem; 1990; 59():253-88. PubMed ID: 2115762
    [No Abstract]   [Full Text] [Related]  

  • 28. Subtle changes in peptide conformation profoundly affect recognition of the non-classical MHC class I molecule HLA-E by the CD94-NKG2 natural killer cell receptors.
    Hoare HL; Sullivan LC; Clements CS; Ely LK; Beddoe T; Henderson KN; Lin J; Reid HH; Brooks AG; Rossjohn J
    J Mol Biol; 2008 Apr; 377(5):1297-303. PubMed ID: 18339401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural basis for a major histocompatibility complex class Ib-restricted T cell response.
    Hoare HL; Sullivan LC; Pietra G; Clements CS; Lee EJ; Ely LK; Beddoe T; Falco M; Kjer-Nielsen L; Reid HH; McCluskey J; Moretta L; Rossjohn J; Brooks AG
    Nat Immunol; 2006 Mar; 7(3):256-64. PubMed ID: 16474394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cutting edge: expression of functional CD94/NKG2A inhibitory receptors on fetal NK1.1+Ly-49- cells: a possible mechanism of tolerance during NK cell development.
    Sivakumar PV; Gunturi A; Salcedo M; Schatzle JD; Lai WC; Kurepa Z; Pitcher L; Seaman MS; Lemonnier FA; Bennett M; Forman J; Kumar V
    J Immunol; 1999 Jun; 162(12):6976-80. PubMed ID: 10358137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-based prediction of MHC-peptide association: algorithm comparison and application to cancer vaccine design.
    Schiewe AJ; Haworth IS
    J Mol Graph Model; 2007 Oct; 26(3):667-75. PubMed ID: 17493854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural implications for the design of molecular vaccines.
    Apostolopoulos V; Yu M; McKenzie IF; Wilson IA
    Curr Opin Mol Ther; 2000 Feb; 2(1):29-36. PubMed ID: 11249650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, gamma delta T cells, and antigen-specific CTL.
    Bakker AB; Phillips JH; Figdor CG; Lanier LL
    J Immunol; 1998 Jun; 160(11):5239-45. PubMed ID: 9605119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isolation and characterization of human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells directed toward the widely expressed tumor T-cell epitopes of the telomerase catalytic subunit.
    Lev A; Denkberg G; Cohen CJ; Tzukerman M; Skorecki KL; Chames P; Hoogenboom HR; Reiter Y
    Cancer Res; 2002 Jun; 62(11):3184-94. PubMed ID: 12036932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cells.
    Brooks AG; Borrego F; Posch PE; Patamawenu A; Scorzelli CJ; Ulbrecht M; Weiss EH; Coligan JE
    J Immunol; 1999 Jan; 162(1):305-13. PubMed ID: 9886400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of an enhancer agonist cytotoxic T lymphocyte peptide from human carcinoembryonic antigen.
    Zaremba S; Barzaga E; Zhu M; Soares N; Tsang KY; Schlom J
    Cancer Res; 1997 Oct; 57(20):4570-7. PubMed ID: 9377571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peptides corresponding to T-cell receptor-HLA contact regions inhibit class I-restricted immune responses.
    Clayberger C; Lyu SC; Pouletty P; Krensky AM
    Transplant Proc; 1993 Feb; 25(1 Pt 1):477-8. PubMed ID: 8438385
    [No Abstract]   [Full Text] [Related]  

  • 38. Role of the major histocompatibility complex class I regions in rat natural killer cell allograft responses in vivo and in vitro.
    Rolstad B
    Chem Immunol; 1996; 64():59-76. PubMed ID: 8942072
    [No Abstract]   [Full Text] [Related]  

  • 39. Structure and function of major histocompatibility complex class I antigens.
    Li XC; Raghavan M
    Curr Opin Organ Transplant; 2010 Aug; 15(4):499-504. PubMed ID: 20613521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The unconventional role of HLA-E: The road less traveled.
    Grant EJ; Nguyen AT; Lobos CA; Szeto C; Chatzileontiadou DSM; Gras S
    Mol Immunol; 2020 Apr; 120():101-112. PubMed ID: 32113130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.